What You Should Know
- The Raise: Montreal-based Secai has closed a $6.2M Series A financing round to expand its footprint across Canada and the United States.
- The Tech: The company offers a two-pronged solution: Voxira (autonomous voice reception) and NoteGen (clinical documentation). Together, they aim to automate both patient access and the medical encounter itself.
- The Credibility: Secai has become the first and only voice AI to receive TGV certification from the Quebec Ministry of Health (August 2025), a massive validation of its safety and compliance in a highly regulated market.
The Dual Engine: Voxira and NoteGen
Secai is tackling the two biggest time-sinks in healthcare simultaneously:
- Voxira (The Front Desk): An autonomous voice receptionist that handles patient communications and appointment workflows. It ensures that no patient call goes unanswered, solving the access challenge created by staffing shortages.
- NoteGen (The Exam Room): A real-time documentation tool that integrates directly with Electronic Medical Records (EMR). It captures the patient encounter and structures the data, freeing the physician to focus on care.
“Clinics are no longer asking whether they should use AI, but how quickly they can deploy it,” said Dr. Ragui Ibrahim, President and CEO of Secai. “Our technology helps clinics reclaim hours of administrative time, increase capacity, and reduce burnout. This funding allows us to scale that impact more broadly.”
In August 2025, the company became the first and only voice AI to receive TGV certification from the Quebec Ministry of Health.
The Expansion Plan
The Series A funding will be used to take this proven model nationwide across Canada and into the United States. The capital will also support deeper integrations with major EMR platforms—the lifeblood of any clinical workflow—and advance R&D in “agentic workflows.”
“With this investment, we’re building the operating system of the modern clinic,” added Dr. Ibrahim.
